Position history for VANGUARD GROUP INC's holdings in ULTRAGENYX PHARMACEUTICAL IN
VANGUARD GROUP INC holds 10.3M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $236.1M as of 2025-Q4. The position was increased (+1.3% shares). RARE represents 0.0% of VANGUARD GROUP INC's portfolio.
Current Value
$236.1M
Current Shares
10.3M
Total Value Change
-$316.4M
Total Shares Change
+318,342
Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.
Increased |
| 10.3M |
+1.3% |
| $236.1M |
| 0.0% |
| $22.78 |
31 |
| 2025-Q3 | Decreased | 10.1M | -0.8% | $304.8M | 0.0% | $30.36 | 0 |
| 2025-Q2 | Increased | 10.2M | +2.2% | $371.4M | 0.0% | $36.52 | 32 |
| 2025-Q1 | Decreased | 10M | -0.4% | $362M | 0.0% | $37.82 | 0 |
| 2024-Q4 | Increased | 10M | +0.9% | $422.2M | 0.0% | $42.27 | 31 |
| 2024-Q3 | New | 9.9M | - | $552.5M | 0.0% | $54.43 | 43 |